EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 -0.5481
March 31, 2026 -1.529
December 31, 2025 -1.282
September 30, 2025 -0.3159
June 30, 2025 -0.5886
March 31, 2025 -0.3463
December 31, 2024 -0.3314
September 30, 2024 -0.2436
June 30, 2024 -0.2279
March 31, 2024 -0.3514
December 31, 2023 -0.5274
September 30, 2023 -0.3885
June 30, 2023 -0.5826
March 31, 2023 -0.5982
December 31, 2022 -0.6566
September 30, 2022 -0.8422
June 30, 2022 -0.6228
March 31, 2022 -0.5367
December 31, 2021 -0.94
Date Value
September 30, 2021 -0.8166
June 30, 2021 -0.7983
March 31, 2021 -0.6467
December 31, 2020 -1.010
September 30, 2020 -0.6782
June 30, 2020 -0.7129
March 31, 2020 -0.4713
December 31, 2019 -0.3906
September 30, 2019 -1.403
June 30, 2019 -2.996
March 31, 2019 -2.13
December 31, 2018 -0.372
September 30, 2018 -0.4765
June 30, 2018 -0.4726
March 31, 2018 -0.0474
December 31, 2017 -0.1919
September 30, 2017 -0.3666
June 30, 2017 -0.3585
March 31, 2017 -0.3718

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
LataMed AI Corp. -0.0004
SCWorx Corp. -1.355
GoodRx Holdings, Inc. 0.0245
Claritev Corp. -3.491
iSpecimen, Inc. -0.9773